Rodgers & Associates’s Vanguard S&P Mid-Cap 400 Growth ETF IVOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$683K Buy
4,671
+444
+11% +$61.3K 0.06% 65
2026
Q1
$529K Buy
4,227
+420
+11% +$53.6K 0.05% 71
2025
Q4
$458K Sell
3,807
-5
-0.1% -$600 0.05% 72
2025
Q3
$455K Buy
3,812
+206
+6% +$24.1K 0.05% 71
2025
Q2
$408K Buy
3,606
+80
+2% +$8.51K 0.04% 72
2025
Q1
$364K Hold
3,526
0.04% 72
2024
Q4
$397K Sell
3,526
-272
-7% -$31.9K 0.05% 73
2024
Q3
$435K Hold
3,798
0.05% 72
2024
Q2
$416K Buy
3,798
+1,178
+45% +$129K 0.05% 71
2024
Q1
$297K Sell
2,620
-50
-2% -$5.17K 0.04% 75
2023
Q4
$262K Sell
2,670
-623
-19% -$57.1K 0.04% 78
2023
Q3
$297K Buy
3,293
+533
+19% +$50.1K 0.04% 71
2023
Q2
$258K Buy
+2,760
New +$245K 0.04% 74

Other funds holding IVOG

Rodgers & Associates's IVOG Position: Q2 2026 in Review

Rodgers & Associates increased its Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) stake by 11% in Q2 2026, buying an estimated $61.3K and bringing the position to 4,671 shares worth $683K. The position accounts for 0.06% of the portfolio, ranked #65.

Rodgers & Associates first reported a position in IVOG in Q2 2023 and has held it in 13 quarters since. 193 funds tracked by Wall St. Rank hold IVOG as of Q2 2026.

  • Rodgers & Associates held 4,671 shares of Vanguard S&P Mid-Cap 400 Growth ETF worth $683K as of Q2 2026.
  • Rodgers & Associates bought 444 Vanguard S&P Mid-Cap 400 Growth ETF shares in Q2 2026, an estimated $61.3K.
  • Vanguard S&P Mid-Cap 400 Growth ETF made up 0.06% of Rodgers & Associates's portfolio in Q2 2026, its #65 holding.
  • Rodgers & Associates first reported a position in Vanguard S&P Mid-Cap 400 Growth ETF in Q2 2023 and has held it in 13 quarters since.
  • 193 funds tracked by Wall St. Rank held Vanguard S&P Mid-Cap 400 Growth ETF as of Q2 2026.

Based on Rodgers & Associates's 13F filing for Q2 2026, filed 21 Jul 2026.